Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Azzouqa AG"'
1
The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma
Autor: Azzouqa AG, Stevenson JP
Publikováno v: OncoTargets and Therapy, Vol Volume 9, Pp 7247-7252 (2016)
Abdel-Ghani Azzouqa,1 James P Stevenson2 1Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 2Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA Abstract: Malignant pleural mesothel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::8fb7421d56290e1fd2b497898faa8e8e
https://www.dovepress.com/the-evolution-of-the-diminishing-role-of-extrapleural-pneumonectomy-in-peer-reviewed-article-OTT
Zobrazit plný text záznamu
2
Akademický článek
Efficacy of gemcitabine in combination with nanoparticle albumin-bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review.
Autor: Kase AM; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA., Azzouqa AG; Cancer Care Institute, Monument Health, Rapid City, South Dakota, USA., Kochuveettil S; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA., Colon-Otero G; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA.
Publikováno v: Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9434-9438. Date of Electronic Publication: 2023 Feb 21.
Zobrazit plný text záznamu
3
Akademický článek
Emerging therapeutic agents for advanced non-small cell lung cancer.
Autor: Chen R; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA., Manochakian R; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA., James L; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA., Azzouqa AG; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA., Shi H; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA., Zhang Y; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA., Zhao Y; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA., Zhou K; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA., Lou Y; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA. Lou.yanyan@mayo.edu.
Publikováno v: Journal of hematology & oncology [J Hematol Oncol] 2020 May 24; Vol. 13 (1), pp. 58. Date of Electronic Publication: 2020 May 24.
Zobrazit plný text záznamu
4
Akademický článek
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities.
Autor: Ailawadhi S; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL. Electronic address: ailawadhi.sikander@mayo.edu., Azzouqa AG; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Hodge D; Department of Health Sciences and Research, Mayo Clinic, Jacksonville, FL., Cochuyt J; Department of Health Sciences and Research, Mayo Clinic, Jacksonville, FL., Jani P; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Ahmed S; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Sher T; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Roy V; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Ailawadhi M; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Alegria VR; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Manochakian R; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Vishnu P; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Grover A; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Abdulazeez MF; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Paulus A; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Chanan-Khan A; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL.
Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2019 Oct; Vol. 19 (10), pp. 619-623. Date of Electronic Publication: 2019 Jun 26.
Zobrazit plný text záznamu
5
Akademický článek
Monoclonal antibody utilization characteristics in patients with multiple myeloma.
Autor: Ailawadhi S; Division of Hematology-Oncology, Mayo Clinic., Sher T; Division of Hematology-Oncology, Mayo Clinic., Azzouqa AG; Division of Hematology-Oncology, Mayo Clinic., Meghji Z; Division of Hematology-Oncology, Mayo Clinic., Jain T; Division of Hematology-Oncology, Mayo Clinic., Jani P; Division of Hematology-Oncology, Mayo Clinic., Ahmed S; Division of Hematology-Oncology, Mayo Clinic., Diehl N; Department of Health Sciences and Research, Mayo Clinic, Jacksonville, Florida., Roy V; Division of Hematology-Oncology, Mayo Clinic., Shah V; Department of Pharmacology, Mayo Clinic, Scottsdale, Arizona, USA., Hodge D; Department of Health Sciences and Research, Mayo Clinic, Jacksonville, Florida., Ailawadhi M; Division of Hematology-Oncology, Mayo Clinic., Alegria VR; Division of Hematology-Oncology, Mayo Clinic., Paulus A; Division of Hematology-Oncology, Mayo Clinic., Chanan-Khan A; Division of Hematology-Oncology, Mayo Clinic., Fonseca R; Division of Hematology-Oncology, Mayo Clinic.
Publikováno v: Anti-cancer drugs [Anticancer Drugs] 2019 Sep; Vol. 30 (8), pp. 859-865.
Zobrazit plný text záznamu
6
Akademický článek
Reducing Unplanned Medical Oncology Readmissions by Improving Outpatient Care Transitions: A Process Improvement Project at the Cleveland Clinic.
Autor: Montero AJ; Cleveland Clinic, Cleveland, OH montero2@ccf.org., Stevenson J; Cleveland Clinic, Cleveland, OH., Guthrie AE; Cleveland Clinic, Cleveland, OH., Best C; Cleveland Clinic, Cleveland, OH., Goodman LM; Cleveland Clinic, Cleveland, OH., Shrotriya S; Cleveland Clinic, Cleveland, OH., Azzouqa AG; Cleveland Clinic, Cleveland, OH., Parala A; Cleveland Clinic, Cleveland, OH., Lagman R; Cleveland Clinic, Cleveland, OH., Bolwell BJ; Cleveland Clinic, Cleveland, OH., Kalaycio ME; Cleveland Clinic, Cleveland, OH., Khorana AA; Cleveland Clinic, Cleveland, OH.
Publikováno v: Journal of oncology practice [J Oncol Pract] 2016 May; Vol. 12 (5), pp. e594-602. Date of Electronic Publication: 2016 Apr 05.
Zobrazit plný text záznamu
7
Akademický článek
Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An ASCO Quality Training Program Project of the Cleveland Clinic Taussig Cancer Institute.
Autor: Goodman LM; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA goodmal2@ccf.org., Moeller MB; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Azzouqa AG; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Guthrie AE; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Dalby CK; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Earl MA; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Cheng C; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Pennell NA; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Shapiro M; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Velcheti V; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Stevenson JP; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA.
Publikováno v: Journal of oncology practice [J Oncol Pract] 2016 Jan; Vol. 12 (1), pp. e101-7.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje